人工智能在慢性髓性白血病 (CML) 疾病预测和管理中的应用:一个范围审查
Malihe Ram1, Mohammad Reza Afrash2, Khadijeh Moulaei3
1Faculty of Medical Sciences, Birjand university of medical sciences, Birjand, Iran.
BMC cancer
|August 20, 2024
概括
人工智能 (AI) 有助于慢性髓性白血病 (CML) 的诊断和治疗. 人工智能模型在分类白血病和预测结果方面显示出高准确性,改善了患者的护理.
科学领域:
- 血液学 血液学 血液学
- 医疗信息学 医疗信息学
- 人工智能的人工智能
背景情况:
- 慢性髓性白血病 (CML) 的诊断和管理存在复杂的挑战.
- 准确预测疾病进展和治疗反应对于有效的CML护理至关重要.
- 人工智能 (AI) 为CML的预测建模和个性化治疗策略提供了先进的解决方案.
研究的目的:
- 审查AI在慢性髓性白血病 (CML) 诊断和管理中的应用.
- 确定常见的AI模型及其在CML相关任务中的表现.
- 突出AI在改善CML患者早期检测和治疗干预方面的潜力.
主要方法:
- 在PubMed,Scopus和Web of Science数据库中进行了广泛的文献搜索,截至2023年4月24日.
- 从选定的文章中提取数据,使用标准化表格,并使用表格和图表呈现.
- PRISMA-ScR检查清单指导了对研究结果的透明报告.
主要成果:
- 该综述包括了12篇文章,重点关注CML中的AI应用.
- 人工智能主要用于瘤诊断/分类 (75%),预测/预后 (17%) 和治疗 (8%).
- 常见的AI模型包括支持向量机 (SVM),极端梯度增强 (XGBoost) 和各种神经网络. 混合卷积神经网络与交互式自学学校 (HCNN-IAS) 和MayGAN在特定的CML诊断任务中表现出高准确度.
结论:
- 人工智能在预测慢性髓性白血病 (CML) 的预后和个性化治疗方面取得了重大进展.
- 集成的人工智能系统增强临床决策并优化患者护理途径.
- 人工智能有助于改善CML管理中的临床结果.
更多相关视频
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
13.9K
07:39Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
40
相关概念视频
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
